Associate Professor Ben Solomon (MBBS, PhD, FRACP) is a Medical Oncologist at the Peter MacCallum Cancer Centre in Melbourne, Australia. After completing a postdoctoral fellowship at the University of Colorado he returned to Peter MacCallum Cancer Centre in 2006 where he practices as a Medical Oncologist with a focus on clinical and translational research in lung cancer, head and neck cancer and phase I studies of novel anti-cancer therapies. He has been involved in the clinical development of targeted therapies in lung cancer, including the phase I through to phase III clinical trials with crizotinib that led to its approval in the treatment of ALK-rearranged NSCLC.